ARDX
Ardelyx, Inc. · Healthcare
Chief Development Officer David P. Rosenbaum sold $166K of Ardelyx, Inc.
Sold$165,743
$6.10Price
27,171Shares
−5%Stake
What ARDX did after the filing
- The stock from Fri, Nov 8 close, $5.07
- −9.7%
- S&P 500, same days
- −0.3%
Measured over 30 trading days, to the Dec 23 close.
Traded Wed, Nov 6. Filed Fri, Nov 8, 1:00 PM ET, during the session. Returns use the Nov 8 close and the Dec 23 close. Not investment advice.